Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

23 Feb 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Cytomegalovirus · Phase 2 · Enrollment 42 · Sponsor: St. Jude Children's Research Hospital

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 23 Feb 2026. The item focuses on Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation. Open the detail page to review the full original feed content.